European Journal of Cancer
Volume 45, Issue 14 , Pages 2552-2561 , September 2009

Health and persistent functional late effects in adult survivors of childhood CNS tumours: A population-based cohort study

  • K.K. Boman

      Affiliations

    • Karolinska Institutet, Department of Women’s and Children’s Health, Childhood Cancer Research Unit, Astrid Lindgren Children’s Hospital Q6:05, S-17176 Stockholm, Sweden
    • Corresponding Author InformationCorresponding author: Tel.: +46 707883305 (mobile), +46 851774931 (office), +46 851772870 (secr.); fax: +46 8320274.
    • ,
  • E. Hovén

      Affiliations

    • Karolinska Institutet, Department of Women’s and Children’s Health, Childhood Cancer Research Unit, Astrid Lindgren Children’s Hospital Q6:05, S-17176 Stockholm, Sweden
    • ,
  • M. Anclair

      Affiliations

    • Karolinska Institutet, Department of Women’s and Children’s Health, Childhood Cancer Research Unit, Astrid Lindgren Children’s Hospital Q6:05, S-17176 Stockholm, Sweden
    • ,
  • B. Lannering

      Affiliations

    • University of Gothenburg, Department of Pediatrics, Pediatric Oncology, Queen Silvia’s Children’s Hospital, SU/Östra, S-416 85 Gothenburg, Sweden
    • ,
  • G. Gustafsson

      Affiliations

    • Karolinska Institutet, Department of Women’s and Children’s Health, Childhood Cancer Research Unit, Astrid Lindgren Children’s Hospital Q6:05, S-17176 Stockholm, Sweden

Received 30 March 2009 ,Revised 6 June 2009 ,Accepted 10 June 2009.

References 

  1. Gustafsson G, Heyman M, Vernby Å. Childhood cancer incidence and survival in Sweden 1985–2005. Stockholm: The Swedish Childhood Cancer Registry; 2007;
  2. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355:1572–1582
  3. Hjern A, Lindblad F, Boman KK. Disability in adult survivors of childhood cancer – a Swedish national cohort study. J Clin Oncol. 2007;25:5262–5266
  4. Lannering B, Marky I, Lundberg A, Olsson E. Long-term sequelae after pediatric brain tumors: their effect on disability and quality of life. Med Pediatr Oncol. 1990;18:304–310
  5. Mulhern RK, Merchant TE, Gajjar A, Reddick WE, Kun LE. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol. 2004;5:399–408
  6. Fouladi M, Langston J, Mulhern R, et al. Silent lacunar lesions detected by magnetic resonance imaging of children with brain tumors: a late sequela of therapy. J Clin Oncol. 2000;18:824–831
  7. Wallace H, Green D. Late effects of childhood cancer. London: Hodder Education; 2003;320 p.
  8. Blaauwbroek R, Stant AD, Groenier KH, et al. Health-related quality of life and adverse late effects in adult (very) long-term childhood cancer survivors. Eur J Cancer. 2007;43:122–130
  9. Hawkins MM, Robison LL. Importance of clinical and epidemiological research in defining the long-term clinical care of pediatric cancer survivors. Pediatr Blood Cancer. 2006;46:174–178
  10. Glaser AW, Furlong W, Walker DA, et al. Applicability of the Health Utilities Index to a population of childhood survivors of central nervous system tumours in the UK. Eur J Cancer. 1999;35:256–261
  11. Barr RD, Simpson T, Whitton A, et al. Health-related quality of life in survivors of tumours of the central nervous system in childhood – a preference-based approach to measurement in a cross-sectional study. Eur J Cancer. 1999;35:248–255
  12. Grant J, Cranston A, Horsman J, et al. Health status and health-related quality of life in adolescent survivors of cancer in childhood. J Adolesc Health. 2006;38:504–510
  13. Alessi D, Dama E, Barr R, et al. Health-related quality of life of long-term childhood cancer survivors: a population-based study from the Childhood Cancer Registry of Piedmont, Italy. Eur J Cancer. 2007;43:2545–2552
  14. Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. International Classification of Childhood Cancer, third edition. Cancer. 2005;103:1457–1467
  15. Horsman J, Furlong W, Feeny D, Torrance G. The Health Utilities Index (HUI(R)): concepts, measurement properties and applications. Health Qual Life Outcomes. 2003;1:54
  16. Furlong WJ, Feeny DH, Torrance GW, Barr RD. The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies. Ann Med. 2001;33:375–384
  17. Feeny D, Furlong W, Torrance GW, et al. Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Med Care. 2002;40:113–128
  18. Glaser A, Kennedy C, Punt J, Walker D. Standardized quantitative assessment of brain tumor survivors treated within clinical trials in childhood. Int J Cancer Suppl. 1999;12:77–82
  19. Kennedy CR, Leyland K. Comparison of screening instruments for disability and emotional/behavioral disorders with a generic measure of health-related quality of life in survivors of childhood brain tumors. Int J Cancer. 1999;12:106–111
  20. Eiser C, Morse R. The measurement of quality of life in children: past and future perspectives. J Dev Behav Pediatr. 2001;22:248–256
  21. Furlong W, Feeny D, Torrance G. Health Utilities Index (HUI) procedures manual: algorithm for determining HUI Mark 2 (HUI2)/Mark 3 (HUI3) health status classification levels, health states single-attribute level utility scores and overall health-related quality of life utility scores from 15-item self-complete health status questionnaires. Dundas, ON, Canada: Health Utilities Inc.; 2002;
  22. Torrance GW, Feeny DH, Furlong WJ, et al. Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2. Med Care. 1996;34:702–722
  23. Drummond M. Introducing economic and quality of life measurements into clinical studies. Ann Med. 2001;33:344–349
  24. Samsa G, Edelman D, Rothman ML, et al. Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics. 1999;15:141–155
  25. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–174
  26. Grootendorst P, Feeny D, Furlong W. Health Utilities Index Mark 3: evidence of construct validity for stroke and arthritis in a population health survey. Med Care. 2000;38:290–299
  27. Foreman NK, Faestel PM, Pearson J, et al. Health status in 52 long-term survivors of pediatric brain tumors. J Neurooncol. 1999;41:47–53
  28. Glaser AW, Abdul RN, U CL, Walker DA. School behaviour and health status after central nervous system tumours in childhood. Br J Cancer. 1997;76:643–650
  29. Mulhern RK. Correlation of the Health Utilities Index Mark 2 cognition scale and neuropsychological functioning among survivors of childhood medulloblastoma. Int J Cancer Suppl. 1999;12:91–94
  30. Mostow EN, Byrne J, Connelly RR, Mulvihill JJ. Quality of life in long-term survivors of CNS tumors of childhood and adolescence. J Clin Oncol. 1991;9:592–599
  31. Maddigan SL, Feeny DH, Johnson JA. Health-related quality of life deficits associated with diabetes and comorbidities in a Canadian National Population Health Survey. Qual Life Res. 2005;14:1311–1320
  32. Kiltie AE, Gattamaneni HR. Survival and quality of life of paediatric intracranial germ cell tumour patients treated at the Christie Hospital, 1972–1993. Med Pediatr Oncol. 1995;25:450–456
  33. Stiggelbout AM, de Vogel-Voogt E. Health state utilities: a framework for studying the gap between the imagined and the real. Value Health. 2008;11:76–87
  34. Schwartz CE, Andresen EM, Nosek MA, Krahn GL. Response shift theory: important implications for measuring quality of life in people with disability. Arch Phys Med Rehabil. 2007;88:529–536

PII: S0959-8049(09)00437-7

doi: 10.1016/j.ejca.2009.06.008

European Journal of Cancer
Volume 45, Issue 14 , Pages 2552-2561 , September 2009

Article Tools

* Image Usage & Resolution